ABCs Report: Haemophilus influenzae, 1998

This webpage is archived for historical purposes and is no longer being maintained or updated.

February 2, 2010: Content on this page kept for historical reasons.

Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network

Print-friendly version of this surveillance report [1 page]

ABCs Areas

California (3 county San Francisco Bay area); Connecticut; Georgia (20 county Atlanta area); Maryland; Minnesota; New York (7 county Rochester area); Oregon; Tennessee (5 urban counties)

ABCs Population

The surveillance areas represent 26,514,662 persons. Source: U.S. Bureau of the Census, 1998

ABCs Case Definition

Invasive Haemophilus influenzae (Hi) disease: isolation of Haemophilus influenzae from normally sterile site in a resident of a surveillance area in 1998.

ABCs Methodology

Project personnel communicated at least monthly with contacts in all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that include information on demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. Serotyping was done on Hi isolates at CDC and state laboratories. Regular laboratory audits assess completeness of active surveillance and detect additional cases.

All rates of invasive Hi disease were calculated using U.S. Bureau of the Census postcensal population estimates for 1998. For national projections, race- and age-specific rates of disease were applied from the aggregate surveillance areas to the race- and age-specific distribution of the 1998 U. S. population. Cases with unknown race were distributed by area based on reported race distribution for known cases within the eight age categories.

Reported ABCs Profiles

Race	No.	(Rate^*)
White	289	(1.4)
Black	78	(1.9)
Other	10	(0.7)
Total	377	(1.4)

Unknown race (n=48) distributed among knowns

^* Cases per 100,000 population for ABCs areas.

Syndrome	Cases No. (%^*)	Deaths No. (%^†)
Meningitis	31 (8.2)	1 (3.2)
Bacteremia without focus	150 (39.8)	25 (16.7)

^*Percent of cases.

^†Deaths per 100 cases.

Age (years)	b No. (Rate^*)	Serotype Non-b No. (Rate^*)	Serotype Non-Type^† No. (Rate^*)	Unknown No. (Rate^*)
<1	3 (0.8)	5 (1.4)	15 (4.2)	2 (0.6)
1	0 (0.0)	4 (1.1)	3 (0.8)	1 (0.3)
2-4	1 (0.1)	1 (0.1)	5 (0.5)	1 (0.1)
5-17	1 (0.02)	2 (0.04)	13 (0.3)	4 (0.1)
18-34	3 (0.05)	7 (0.1)	13 (0.2)	9 (0.1)
35-49	6 (0.1)	5 (0.1)	26 (0.4)	11 (0.2)
50-64	2 (0.05)	14 (0.4)	28 (0.8)	14 (0.4)
≥ 65	10 (0.3)	43 (1.4)	95 (3.0)	30 (1.0)
Total	26 (0.1)	81 (0.3)	198 (0.7)	72 (0.3)

^*Cases per 100,000 population for ABCs areas

^† Non-typeable isolates

National Projection for Invasive Disease

Cases: 3,900 (1.5/100,000)
Deaths: 500 (0.2/100,000)

Healthy People 2010 Update

Invasive Haemophilus influenzae type b disease

Objective: Decrease the incidence of invasive Haemophilus influenzae type b disease to zero cases per 100,000 persons less than 5 years of age.

Race	2010 Objective	1998 Rate^*
White	0/100,000	—/100,000
Black	0/100,000	—/100,000
Other	0/100,000	—/100,000
Total	0/100,000	0.2/100,000

^* Projected cases per 100,000 U.S. population < 5 years.

Citation

Centers for Disease Control and Prevention. 1999 Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998.

Top of Page